Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4547056
Max Phase: Preclinical
Molecular Formula: C17H21ClN2O4S
Molecular Weight: 384.89
Molecule Type: Unknown
Associated Items:
ID: ALA4547056
Max Phase: Preclinical
Molecular Formula: C17H21ClN2O4S
Molecular Weight: 384.89
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C(=O)CCNC(=O)/C=C/c1cccc(Cl)c1)C1CCS(=O)(=O)C1
Standard InChI: InChI=1S/C17H21ClN2O4S/c1-20(15-8-10-25(23,24)12-15)17(22)7-9-19-16(21)6-5-13-3-2-4-14(18)11-13/h2-6,11,15H,7-10,12H2,1H3,(H,19,21)/b6-5+
Standard InChI Key: VCUSHPMBOUAOFU-AATRIKPKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 384.89 | Molecular Weight (Monoisotopic): 384.0911 | AlogP: 1.50 | #Rotatable Bonds: 6 |
Polar Surface Area: 83.55 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 0.29 | CX LogD: 0.29 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.75 | Np Likeness Score: -1.78 |
1. (2015) Klf5 modulators, |
Source(1):